Abstract
The Ras homolog enriched in striatum, Rhes, is the product of a thyroid hormone-regulated gene during brain development. Rhes and the dexamethasone-induced Dexras1 define a novel distinct subfamily of proteins within the Ras family, characterized by an extended variable domain in the carboxyl terminal region. We have carried this study because there is a complete lack of knowledge on Rhes signaling. We show that in PC12 cells, Rhes is targeted to the plasma membrane by farnesylation. We demonstrate that about 30% of the native Rhes protein is bound to GTP and this proportion is unaltered by typical Ras family nucleotide exchange factors. However, Rhes is not transforming in murine fibroblasts. We have also examined the role of Rhes in cell signaling. Rhes does not stimulate the ERK pathway. By contrast, it binds to and activates PI3K. On the other hand, we demonstrate that Rhes impairs the activation of the cAMP/PKA pathway by thyroid-stimulating hormone, and by an activated β2 adrenergic receptor by a mechanism that suggests uncoupling of the receptor to its cognate heterotrimeric complex. Overall, our results provide the initial insights into the role in signal transduction of this novel Ras family member.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bairoch A and Apweiler R . (2000). Nucleic Acids Res., 28, 45–48.
Bauer B, Mirey G, Vetter IR, Garcia-Ranea JA, Valencia A, Wittinghofer A, Camonis JH and Cool RH . (1999). J. Biol. Chem., 274, 17763–17770.
Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ and Der CJ . (1998). Oncogene, 17, 1395–1413.
Chan SL, Monks LK, Gao H, Deaville P and Morgan NG . (2002). Br. J. Pharmacol., 136, 31–36.
Chuang E, Barnard D, Hettich L, Zhang XF, Avruch J and Marshall MS . (1994). Mol. Cell. Biol., 14, 5318–5325.
Cismowski MJ, Ma C, Ribas C, Xie X, Spruyt M, Lizano JS, Lanier SM and Duzic E . (2000). J. Biol. Chem., 275, 23421–23424.
Cismowski MJ, Takesono A, Ma C, Lizano JS, Xie X, Fuernkranz H, Lanier SM and Duzic E . (1999). Nat. Biotechnol., 17, 878–883.
Clanton DJ, Hattori S and Shih TY . (1986). Proc. Natl. Acad. Sci. USA, 83, 5076–5080.
Crespo P, Cachero TG, Xu N and Gutkind JS . (1995). J. Biol. Chem., 270, 25259–25265.
Daaka Y, Luttrell LM and Lefkowitz RJ . (1997). Nature, 390, 88–91.
Datta K, Bellacosa A, Chan TO and Tsichlis PN . (1996). J. Biol. Chem., 271, 30835–30839.
Delong GR, Stanbury JB and Fierro-Benítez R . (1985). Develop. Med. Child Neurol., 27, 317–324.
Falk JD, Vargiu P, Foye PE, Usui H, Perez J, Danielson PE, Lerner DL, Bernal J and Sutcliffe JG . (1999). J. Neurosci. Res., 57, 782–788.
Fang M, Jaffrey SR, Sawa A, Ye K, Luo X and Snyder SH . (2000). Neuron, 28, 183–193.
Farrell FX, Yamamoto K and Lapetina EG . (1993). Biochem. J., 289 (Part 2), 349–355.
Foster R, Hu KQ, Lu Y, Nolan KM, Thissen J and Settleman J . (1996). Mol. Cell. Biol., 16, 2689–2699.
Graham TE, Key TA, Kilpatrick K and Dorin RI . (2001). Endocrinology, 142, 2631–2640.
Graham TE, Prossnitz ER and Dorin RI . (2002). J. Biol. Chem., 277, 10876–10882.
Henikoff S and Henikoff JG . (1992). Proc. Natl. Acad. Sci. USA, 89, 10915–10919.
Jaffrey SR, Fang M and Snyder SH . (2002). Chem. Biol., 9, 1329–1335.
Kemppainen RJ and Behrend EN . (1998). J. Biol. Chem., 273, 3129–3131.
Landis CA, Masters SB, Spada A, Pace AM, Bourne HR and Vallar L . (1989). Nature, 340, 692–696.
Lerner EC, Qian Y, Blaskovich MA, Fossum RD, Vogt A, Sun J, Cox AD, Der CJ, Hamilton AD and Sebti SM . (1995a). J. Biol. Chem., 270, 26802–26806.
Lerner EC, Qian Y, Hamilton AD and Sebti SM . (1995b). J. Biol. Chem., 270, 26770–26773.
Mellon PL, Windle JJ, Goldsmith PC, Padula CA, Roberts JL and Weiner RI . (1990). Neuron, 5, 1–10.
Mott HR, Carpenter JW and Campbell SL . (1997). Biochemistry, 36, 3640–3644.
Muñoz A, Wrighton C, Seliger B, Bernal J and Beug H . (1993). J. Cell Biol., 121, 423–438.
Park J, Teichmann SA, Hubbard T and Chothia C . (1997). J. Mol. Biol., 273, 349–354.
Reuther GW and Der CJ . (2000). Curr. Opin. Cell. Biol., 12, 157–165.
Samama P, Cotecchia S, Costa T and Lefkowitz RJ . (1993). J. Biol. Chem., 268, 4625–4636.
St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B and Kinzler KW . (2000). Science, 289, 1197–1202.
Takesono A, Nowak MW, Cismowski M, Duzic E and Lanier SM . (2002). J. Biol. Chem., 277, 13827–13830.
Thompson JD, Higgins DG and Gibson TJ . (1994). Nucleic Acids Res., 22, 4673–4680.
Vargiu P, Morte B, Manzano J, Perez J, de Abajo R, Gregor Sutcliffe J and Bernal J . (2001). Brain Res. Mol. Brain Res., 94, 1–8.
Walter M, Clark SG and Levinson AD . (1986). Science, 233, 649–652.
Wittinghofer A and Valencia A . (1995). Guidebook to the Small GTPases, Zerial M, Huber LA, Tooze J (eds). Oxford University Press: Oxford, New York, Tokyo, pp. 20–29.
Acknowledgements
We acknowledge the technical help provided by Eulalia Moreno. Supported by Grants 08.5/0044/2000 1 from the Community of Madrid, BFI2002-00489 from the Ministry of Science and Technology, European Union Q663-2000-00930 and FIS, Instituto de Salud Carlos III, Red de Centros RCMN (C03/08), Madrid, Spain.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vargiu, P., Abajo, R., Garcia-Ranea, J. et al. The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors. Oncogene 23, 559–568 (2004). https://doi.org/10.1038/sj.onc.1207161
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207161
Keywords
This article is cited by
-
The striatal-enriched protein Rhes is a critical modulator of cocaine-induced molecular and behavioral responses
Scientific Reports (2019)
-
The Emerging Roles of Ferroptosis in Huntington’s Disease
NeuroMolecular Medicine (2019)
-
MicroRNA-101 inhibits the expression of Rhes, a striatal-enriched small G-protein, at the post-transcriptional level in vitro
BMC Research Notes (2018)
-
Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion
Scientific Reports (2015)
-
Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA–induced dyskinesia
Nature Neuroscience (2012)